4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-017457
Senior Vice President and CFO sold 16,750 shares at an average $7.54 ($126,325)
- Senior Vice President and CFO acquired 16,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-02 | Exercise or conversion : show line 1 in the form | +7,750 | $5.51 | $42,703 | 140,426 | D |
| 2019-05-02 | Sale : show line 2 in the form | −7,750 | $7.30 | $56,575 | 132,676 | D |
| 2019-05-06 | Exercise or conversion : show line 3 in the form | +9,000 | $5.51 | $49,590 | 141,676 | D |
| 2019-05-06 | Sale : show line 4 in the form | −9,000 | $7.75 | $69,750 | 132,676 | D |
| Open-market sales · 16,750 sh · avg $7.54 · $126,325 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-05-02 | Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) | −7,750 | 159,750 | D |
| 2019-05-06 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −9,000 | 150,750 | D |
Loading xslF345X03/form4.xml…